Diabetes Increases Formation of Advanced Glycation End Products on Sarco(endo)plasmic Reticulum Ca2+-ATPase

Keshore R. Bidasee, Yinong Zhang, Chun Hong Shao, Mu Wang, Kaushik P. Patel, Ü Deniz Dincer, Henry R. Besch

Research output: Contribution to journalArticle

151 Citations (Scopus)

Abstract

Prolongation of relaxation is a hallmark of diabetic cardiomyopathy. Most studies attribute this defect to decreases in sarco(endo)plasmic reticulum Ca2+-AT-Pase (SERCA2a) expression and SERCA2a-to-phospholamban (PLB) ratio. Since its turnover rate is slow, SERCA2a is susceptible to posttranslational modifications during diabetes. These modifications could in turn compromise conformational rearrangements needed to translocate calcium ions, also leading to a decrease in SERCA2a activity. In the present study one such modification was investigated, namely advanced glycation end products (AGEs). Hearts from 8-week streptozotocin-induced diabetic (8D) rats showed typical slowing in relaxation, confirming cardiomyopathy. Hearts from 8D animals also expressed lower levels of SERCA2a protein and higher levels of PLB. Analysis of matrix-assisted laser desorption/ionization time-of-flight mass data files from trypsin-digested SERCA2a revealed several cytosolic SERCA2a peptides from 8D modified by single noncrosslinking AGEs. Crosslinked AGEs were also found. Lysine residues within actuator and phosphorylation domains were cross-linked to arginine residues within the nucleotide binding domain via pentosidine AGEs. Two weeks of insulin-treatment initiated after 6 weeks of diabetes attenuated these changes. These data demonstrate for the first time that AGEs are formed on SERCA2a during diabetes, suggesting a novel mechanism by which cardiac relaxation can be slowed during diabetes.

Original languageEnglish
Pages (from-to)463-473
Number of pages11
JournalDiabetes
Volume53
Issue number2
DOIs
StatePublished - Feb 2004

Fingerprint

Reticulum
Advanced Glycosylation End Products
Calcium-Transporting ATPases
Diabetic Cardiomyopathies
Information Storage and Retrieval
Post Translational Protein Processing
Streptozocin
Cardiomyopathies
Trypsin
Lysine
Arginine
Lasers
Nucleotides
Phosphorylation
Ions
Insulin
Calcium
Peptides

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Bidasee, K. R., Zhang, Y., Shao, C. H., Wang, M., Patel, K. P., Dincer, Ü. D., & Besch, H. R. (2004). Diabetes Increases Formation of Advanced Glycation End Products on Sarco(endo)plasmic Reticulum Ca2+-ATPase. Diabetes, 53(2), 463-473. https://doi.org/10.2337/diabetes.53.2.463

Diabetes Increases Formation of Advanced Glycation End Products on Sarco(endo)plasmic Reticulum Ca2+-ATPase. / Bidasee, Keshore R.; Zhang, Yinong; Shao, Chun Hong; Wang, Mu; Patel, Kaushik P.; Dincer, Ü Deniz; Besch, Henry R.

In: Diabetes, Vol. 53, No. 2, 02.2004, p. 463-473.

Research output: Contribution to journalArticle

Bidasee, Keshore R. ; Zhang, Yinong ; Shao, Chun Hong ; Wang, Mu ; Patel, Kaushik P. ; Dincer, Ü Deniz ; Besch, Henry R. / Diabetes Increases Formation of Advanced Glycation End Products on Sarco(endo)plasmic Reticulum Ca2+-ATPase. In: Diabetes. 2004 ; Vol. 53, No. 2. pp. 463-473.
@article{adac2a59c11a41ceb7b458fe7ba6245d,
title = "Diabetes Increases Formation of Advanced Glycation End Products on Sarco(endo)plasmic Reticulum Ca2+-ATPase",
abstract = "Prolongation of relaxation is a hallmark of diabetic cardiomyopathy. Most studies attribute this defect to decreases in sarco(endo)plasmic reticulum Ca2+-AT-Pase (SERCA2a) expression and SERCA2a-to-phospholamban (PLB) ratio. Since its turnover rate is slow, SERCA2a is susceptible to posttranslational modifications during diabetes. These modifications could in turn compromise conformational rearrangements needed to translocate calcium ions, also leading to a decrease in SERCA2a activity. In the present study one such modification was investigated, namely advanced glycation end products (AGEs). Hearts from 8-week streptozotocin-induced diabetic (8D) rats showed typical slowing in relaxation, confirming cardiomyopathy. Hearts from 8D animals also expressed lower levels of SERCA2a protein and higher levels of PLB. Analysis of matrix-assisted laser desorption/ionization time-of-flight mass data files from trypsin-digested SERCA2a revealed several cytosolic SERCA2a peptides from 8D modified by single noncrosslinking AGEs. Crosslinked AGEs were also found. Lysine residues within actuator and phosphorylation domains were cross-linked to arginine residues within the nucleotide binding domain via pentosidine AGEs. Two weeks of insulin-treatment initiated after 6 weeks of diabetes attenuated these changes. These data demonstrate for the first time that AGEs are formed on SERCA2a during diabetes, suggesting a novel mechanism by which cardiac relaxation can be slowed during diabetes.",
author = "Bidasee, {Keshore R.} and Yinong Zhang and Shao, {Chun Hong} and Mu Wang and Patel, {Kaushik P.} and Dincer, {{\"U} Deniz} and Besch, {Henry R.}",
year = "2004",
month = "2",
doi = "10.2337/diabetes.53.2.463",
language = "English",
volume = "53",
pages = "463--473",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "2",

}

TY - JOUR

T1 - Diabetes Increases Formation of Advanced Glycation End Products on Sarco(endo)plasmic Reticulum Ca2+-ATPase

AU - Bidasee, Keshore R.

AU - Zhang, Yinong

AU - Shao, Chun Hong

AU - Wang, Mu

AU - Patel, Kaushik P.

AU - Dincer, Ü Deniz

AU - Besch, Henry R.

PY - 2004/2

Y1 - 2004/2

N2 - Prolongation of relaxation is a hallmark of diabetic cardiomyopathy. Most studies attribute this defect to decreases in sarco(endo)plasmic reticulum Ca2+-AT-Pase (SERCA2a) expression and SERCA2a-to-phospholamban (PLB) ratio. Since its turnover rate is slow, SERCA2a is susceptible to posttranslational modifications during diabetes. These modifications could in turn compromise conformational rearrangements needed to translocate calcium ions, also leading to a decrease in SERCA2a activity. In the present study one such modification was investigated, namely advanced glycation end products (AGEs). Hearts from 8-week streptozotocin-induced diabetic (8D) rats showed typical slowing in relaxation, confirming cardiomyopathy. Hearts from 8D animals also expressed lower levels of SERCA2a protein and higher levels of PLB. Analysis of matrix-assisted laser desorption/ionization time-of-flight mass data files from trypsin-digested SERCA2a revealed several cytosolic SERCA2a peptides from 8D modified by single noncrosslinking AGEs. Crosslinked AGEs were also found. Lysine residues within actuator and phosphorylation domains were cross-linked to arginine residues within the nucleotide binding domain via pentosidine AGEs. Two weeks of insulin-treatment initiated after 6 weeks of diabetes attenuated these changes. These data demonstrate for the first time that AGEs are formed on SERCA2a during diabetes, suggesting a novel mechanism by which cardiac relaxation can be slowed during diabetes.

AB - Prolongation of relaxation is a hallmark of diabetic cardiomyopathy. Most studies attribute this defect to decreases in sarco(endo)plasmic reticulum Ca2+-AT-Pase (SERCA2a) expression and SERCA2a-to-phospholamban (PLB) ratio. Since its turnover rate is slow, SERCA2a is susceptible to posttranslational modifications during diabetes. These modifications could in turn compromise conformational rearrangements needed to translocate calcium ions, also leading to a decrease in SERCA2a activity. In the present study one such modification was investigated, namely advanced glycation end products (AGEs). Hearts from 8-week streptozotocin-induced diabetic (8D) rats showed typical slowing in relaxation, confirming cardiomyopathy. Hearts from 8D animals also expressed lower levels of SERCA2a protein and higher levels of PLB. Analysis of matrix-assisted laser desorption/ionization time-of-flight mass data files from trypsin-digested SERCA2a revealed several cytosolic SERCA2a peptides from 8D modified by single noncrosslinking AGEs. Crosslinked AGEs were also found. Lysine residues within actuator and phosphorylation domains were cross-linked to arginine residues within the nucleotide binding domain via pentosidine AGEs. Two weeks of insulin-treatment initiated after 6 weeks of diabetes attenuated these changes. These data demonstrate for the first time that AGEs are formed on SERCA2a during diabetes, suggesting a novel mechanism by which cardiac relaxation can be slowed during diabetes.

UR - http://www.scopus.com/inward/record.url?scp=0842266824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0842266824&partnerID=8YFLogxK

U2 - 10.2337/diabetes.53.2.463

DO - 10.2337/diabetes.53.2.463

M3 - Article

C2 - 14747299

AN - SCOPUS:0842266824

VL - 53

SP - 463

EP - 473

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 2

ER -